These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 7975563)
1. Selective targeting of the immune response in autoimmune demyelination. Oksenberg JR West J Med; 1994 Sep; 161(3):255-9. PubMed ID: 7975563 [TBL] [Abstract][Full Text] [Related]
2. [Demyelination and autoimmunity]. Lebar R Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694 [TBL] [Abstract][Full Text] [Related]
3. Antigen-specific therapies in multiple sclerosis. Sospedra M; Martin R Int Rev Immunol; 2005; 24(5-6):393-413. PubMed ID: 16318988 [TBL] [Abstract][Full Text] [Related]
4. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network. Weathington NM; Blalock JE Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598 [TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases]. Lassmann H Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993 [TBL] [Abstract][Full Text] [Related]
6. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides. Fontoura P; Garren H; Steinman L Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989 [TBL] [Abstract][Full Text] [Related]
7. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Lam-Tse WK; Lernmark A; Drexhage HA Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056 [TBL] [Abstract][Full Text] [Related]
11. Design of effective immunotherapy for human autoimmunity. Feldmann M; Steinman L Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214 [TBL] [Abstract][Full Text] [Related]
12. Treating autoimmune diseases through restoration of antigen-specific immune tolerance. Wolfraim LA Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252 [TBL] [Abstract][Full Text] [Related]
13. The immunopathogenesis of multiple sclerosis. Giovannoni G Baillieres Clin Neurol; 1997 Oct; 6(3):387-407. PubMed ID: 10101580 [TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures. Karussis D; Slavin S J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562 [TBL] [Abstract][Full Text] [Related]
15. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Miller SD; Turley DM; Podojil JR Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
17. [Autoimmunity]. Müller C Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931 [TBL] [Abstract][Full Text] [Related]
18. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis. Dal Canto RA; Costa G; Shaw MD; Seroogy C; Nolan GP; Fathman CG Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):83-91. PubMed ID: 9831193 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of multiple sclerosis. Weiner HL; Hafler DA Ann Neurol; 1988 Mar; 23(3):211-22. PubMed ID: 3288084 [TBL] [Abstract][Full Text] [Related]
20. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Voskuhl RR; Pitchekian-Halabi H; MacKenzie-Graham A; McFarland HF; Raine CS Ann Neurol; 1996 Jun; 39(6):724-33. PubMed ID: 8651644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]